D
Debopam Samanta
Researcher at University of Arkansas for Medical Sciences
Publications - 120
Citations - 718
Debopam Samanta is an academic researcher from University of Arkansas for Medical Sciences. The author has contributed to research in topics: Epilepsy & Medicine. The author has an hindex of 10, co-authored 103 publications receiving 371 citations. Previous affiliations of Debopam Samanta include Maulana Azad Medical College & University of Virginia.
Papers
More filters
Journal ArticleDOI
PCDH19-Related Epilepsy Syndrome: A Comprehensive Clinical Review
TL;DR: Clinical features of PCDH19-related epilepsy are reviewed based on a comprehensive literature review (MEDLINE using PubMed and OvidSP vendors with appropriate keywords to incorporate recent evidence), personal practice, and experience, to find opportunities in precision therapy.
Journal ArticleDOI
Cannabidiol: A Review of Clinical Efficacy and Safety in Epilepsy.
TL;DR: Cannabidiol has better antiepileptic potential than tetrahydrocannabinol and may have a novel anticonvulsant effect, but it has broad drug-drug interactions with several agents, including inducer and inhibitor of CYP3A4 or CYP2C19.
Journal ArticleDOI
Underutilization of epilepsy surgery: Part I: A scoping review of barriers
Debopam Samanta,Adam P. Ostendorf,Adam P. Ostendorf,Erin Willis,Rani K. Singh,Satyanarayana Gedela,Ravindra Arya,Ravindra Arya,M. Scott Perry +8 more
TL;DR: In this paper, the authors compile known significant barriers to epilepsy surgery, originating from both patient/family-related factors and physician/health system components, including individual and epilepsy characteristics which bias towards continued preferential use of poorly effective medications, as well as patient perspectives and misconceptions of surgical risks and benefits.
Journal ArticleDOI
Evidence-based decision support for neurological diagnosis reduces errors and unnecessary workup.
Michael M. Segal,Marc S. Williams,Andrea L. Gropman,Alcy Torres,Rob Forsyth,Anne M. Connolly,Ayman W. El-Hattab,Seth J. Perlman,Debopam Samanta,Sumit Parikh,Steven G. Pavlakis,Lynn Feldman,Rebecca A. Betensky,Sidney M. Gospe +13 more
TL;DR: Using vignettes of real cases and the SimulConsult diagnostic decision support software, neurologists listed a differential diagnosis and workup before and after using the decision support to reduce errors and save on unnecessary testing.
Journal ArticleDOI
Sneddon Syndrome: A Comprehensive Overview.
TL;DR: Neuropsychiatric prognosis of SS is relatively poor with predominant deficits in the concentration, attention, visual perception, and visuospatial skills, and routine use of anti-inflammatory or immunosuppressive therapies is controversial.